Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

被引:0
|
作者
M. Petrillo
P. De Iaco
S. Cianci
M. Perrone
B. Costantini
C. Ronsini
G. Scambia
A. Fagotti
机构
[1] Catholic University of the Sacred Heart,Department of Obstetrics and Gynecology
[2] University of Bologna,Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, S. Orsola Hospital
[3] University of Perugia,Division of Minimally Invasive Gynecological Surgery, St. Maria Hospital
来源
关键词
Peritoneal Cancer Index; Hyperthermic Intraperitoneal Chemotherapy; Memorial Sloan Kettering Cancer Center; Optimal Cytoreduction; Interval Debulking Surgery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1660 / 1665
页数:5
相关论文
共 50 条
  • [21] Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Advanced Ovarian Cancer: A 2-year Survival Analysis Study
    Farzaneh, Farah
    Ashtiani, Azadeh Jafari
    Bohlooli, Mehrdad
    Hosseini, Maryam Sadat
    CURRENT WOMENS HEALTH REVIEWS, 2024, 20 (04)
  • [22] Secondary Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for Advanced or Recurrent Mucinous Ovarian Cancer
    Conley, Aliyah B.
    Fournier, Keith F.
    Sood, Anil K.
    Frumovitz, Michael
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (05): : 1019 - 1023
  • [23] Postoperative morbidity after secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer: An exploratory analysis of a randomized phase II study evaluating hyperthermic intraperitoneal chemotherapy
    Praiss, Aaron
    Moukarzel, Lea
    Chi, Dennis
    Sonoda, Yukio
    Roche, Kara Long
    Gardner, Ginger
    Tew, William
    Grisham, Rachel
    O'Cearbhaill, Roisin
    Zivanovic, Oliver
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S260 - S260
  • [24] CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY IMPROVES SURVIVAL IN PATIENTS WITH STAGE IIIC OVARIAN CANCER
    Li, Zhen
    Cai, Hongbing
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 233 - 233
  • [25] RECURRENT OVARIAN CANCER TREATED BY SECONDARY CYTOREDUCTIVE SURGERY AND HIPEC
    Panoskaltsis, T.
    Tzavara, C.
    Pallas, N.
    Karamveri, C.
    Kiziridis, D.
    Hristakis, C.
    Kyriakopoulos, V.
    Kalakonas, A.
    Vaikos, D.
    Tentes, A-A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A505 - A506
  • [26] Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer
    Ayhan, Ali
    Akilli, Huseyin
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 152 (02) : 202 - 207
  • [27] CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOPERFUSION (HIPEC) IN COMBINED TREATMENT OF RECURRENT OVARIAN CANCER
    Yarema, R.
    Fetsych, T.
    Volodko, N.
    Ohorchak, M.
    Mylyan, Y.
    Oliynyk, Y.
    Zubarev, M.
    Gyrya, P.
    Kovalchuk, Y.
    Safiyan, V.
    Karelin, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1541 - 1541
  • [28] Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis
    Baek, Min-Hyun
    Park, Eun Young
    Ha, Hyeong In
    Park, Sang-Yoon
    Lim, Myong Cheol
    Fotopoulou, Christina
    Bristow, Robert E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (15) : 1659 - +
  • [29] Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up
    Fagotti, Anna
    Costantini, Barbara
    Petrillo, Marco
    Vizzielli, Giuseppe
    Fanfani, Francesco
    Margariti, Pasquale Alessandro
    Turco, Luigi Carlo
    Piovano, Elisa
    Scambia, Giovanni
    GYNECOLOGIC ONCOLOGY, 2012, 127 (03) : 502 - 505
  • [30] Cytoreductive Surgery (CRS) Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Platinum-Sensitive Recurrence Epithelial Ovarian Cancer With HRR Mutation: A Phase III Randomized Clinical Trial
    Qi, Yuwen
    Zhang, Yaxing
    Shi, Yuying
    Yao, Shijie
    Dai, Mengyuan
    Cai, Hongbing
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21